Insider Transactions Reported by 8 Insiders of Kairos Pharma, LTD.

Symbol
KAPA on NYSE
Location
Los Angeles, CA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Kairos Pharma, LTD. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John S. Yu CEO and Chairman, Director, 10%+ Owner $6,101,344 08 Oct 2025
Neil Bhowmick Chief Scientific Officer $931,334 08 Oct 2025
Ramachandran Murali VP of Research and Development $329,481 08 Oct 2025
Doug Samuelson Chief Financial Officer $322,342 08 Oct 2025
Rahul Singhvi Director $54,124 08 Oct 2025
Hyun W. Bae Director $52,092 16 Sep 2025
Hansoo Michael Keyoung Director $31,992 16 Sep 2025
Rosemary Mazanet Director 16 Sep 2024

Recent Insider Transactions by Companies or Individuals for Kairos Pharma, LTD.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Neil Bhowmick KAPA COMMON STOCK Award 15.1% 171,756 1,311,739 08 Oct 2025 Direct
Hyun W. Bae KAPA COMMON STOCK Award 35.2% 19,084 73,370 08 Oct 2025 Direct
Ramachandran Murali KAPA COMMON STOCK Award 104% 152,672 299,529 08 Oct 2025 Direct
Hansoo Michael Keyoung KAPA COMMON STOCK Award 190.8% 19,084 29,084 08 Oct 2025 Direct
Rahul Singhvi KAPA COMMON STOCK Award 63.4% 19,084 49,204 08 Oct 2025 Direct
Doug Samuelson KAPA COMMON STOCK Award 108.8% 152,672 293,039 08 Oct 2025 Direct
John S. Yu KAPA COMMON STOCK Award 486% 190,840 230,105 08 Oct 2025 Direct
Hyun W. Bae KAPA COMMON STOCK Award 22.6% 10,000 54,286 16 Sep 2025 Direct
Hansoo Michael Keyoung KAPA COMMON STOCK Award 10,000 10,000 16 Sep 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.